Published in EMBO Mol Med on December 11, 2014
Is REDD1 a Metabolic Éminence Grise? Trends Endocrinol Metab (2016) 0.77
Discovery of Compound A - a selective activator of the glucocorticoid receptor with anti-inflammatory and anti-cancer activity. Oncotarget (2015) 0.77
Selective Activator of the Glucocorticoid Receptor Compound A Dissociates Therapeutic and Atrophogenic Effects of Glucocorticoid Receptor Signaling in Skin. J Cancer Prev (2015) 0.76
DNA Damage-Inducible Transcript 4 Is an Innate Surveillant of Hair Follicular Stress in Vitamin D Receptor Knockout Mice and a Regulator of Wound Re-Epithelialization. Int J Mol Sci (2016) 0.75
An inhaled dose of budesonide induces genes involved in transcription and signaling in the human airways: enhancement of anti- and proinflammatory effector genes. Pharmacol Res Perspect (2016) 0.75
Inhibitory Effect of Valencene on the Development of Atopic Dermatitis-Like Skin Lesions in NC/Nga Mice. Evid Based Complement Alternat Med (2016) 0.75
Important role of kallikrein 6 for the development of keratinocyte proliferative resistance to topical glucocorticoids. Oncotarget (2016) 0.75
Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc (2009) 137.99
Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res (2008) 54.83
Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy (2012) 20.08
Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J Cell Biol (1988) 16.82
Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery. J Virol (1998) 8.21
Evidence based selection of housekeeping genes. PLoS One (2007) 7.90
Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1/TSC2 tumor suppressor complex. Genes Dev (2004) 7.51
Computational repositioning of the anticonvulsant topiramate for inflammatory bowel disease. Sci Transl Med (2011) 5.30
Hypoxia regulates TSC1/2-mTOR signaling and tumor suppression through REDD1-mediated 14-3-3 shuttling. Genes Dev (2008) 4.52
miR-221 overexpression contributes to liver tumorigenesis. Proc Natl Acad Sci U S A (2009) 4.15
The interplay between the glucocorticoid receptor and nuclear factor-kappaB or activator protein-1: molecular mechanisms for gene repression. Endocr Rev (2003) 3.40
Identification of a novel hypoxia-inducible factor 1-responsive gene, RTP801, involved in apoptosis. Mol Cell Biol (2002) 3.30
REDD1, a developmentally regulated transcriptional target of p63 and p53, links p63 to regulation of reactive oxygen species. Mol Cell (2002) 3.29
Regulation of mTOR and cell growth in response to energy stress by REDD1. Mol Cell Biol (2005) 3.14
The key roles of elongases and desaturases in mammalian fatty acid metabolism: Insights from transgenic mice. Prog Lipid Res (2009) 2.80
Microarray analysis reveals glucocorticoid-regulated survival genes that are associated with inhibition of apoptosis in breast epithelial cells. Cancer Res (2004) 2.35
Distinct fibroblast lineages determine dermal architecture in skin development and repair. Nature (2013) 2.29
Dexamethasone represses signaling through the mammalian target of rapamycin in muscle cells by enhancing expression of REDD1. J Biol Chem (2006) 1.78
Desmoglein 1-dependent suppression of EGFR signaling promotes epidermal differentiation and morphogenesis. J Cell Biol (2009) 1.73
Dissociation of transactivation from transrepression by a selective glucocorticoid receptor agonist leads to separation of therapeutic effects from side effects. Proc Natl Acad Sci U S A (2003) 1.71
Rtp801, a suppressor of mTOR signaling, is an essential mediator of cigarette smoke-induced pulmonary injury and emphysema. Nat Med (2010) 1.67
Crosstalk between glucocorticoid receptor and nutritional sensor mTOR in skeletal muscle. Cell Metab (2011) 1.67
Before they were fat: adipocyte progenitors. Cell Metab (2008) 1.58
Mechanisms of glucocorticoid receptor action in noninflammatory and inflammatory cells. Proc Am Thorac Soc (2004) 1.50
Epithelial cells in the hair follicle bulge do not contribute to epidermal regeneration after glucocorticoid-induced cutaneous atrophy. J Invest Dermatol (2007) 1.49
REDD1, an inhibitor of mTOR signalling, is regulated by the CUL4A-DDB1 ubiquitin ligase. EMBO Rep (2009) 1.44
Glucocorticoid therapy-induced skin atrophy. Exp Dermatol (2006) 1.40
Inhibition of oxygen-induced retinopathy in RTP801-deficient mice. Invest Ophthalmol Vis Sci (2004) 1.39
Growth control under stress: mTOR regulation through the REDD1-TSC pathway. Cell Cycle (2005) 1.33
Suppressors of cytokine signalling: SOCS. APMIS (2002) 1.33
How glucocorticoid receptors modulate the activity of other transcription factors: a scope beyond tethering. Mol Cell Endocrinol (2012) 1.30
Glucocorticoid-regulated transcription factors. Pulm Pharmacol Ther (2001) 1.21
Tumor suppressor activity of glucocorticoid receptor in the prostate. Oncogene (2006) 1.19
Dexamethasone inhibits the antigen presentation of dendritic cells in MHC class II pathway. Immunol Lett (2001) 1.17
On the trail of the glucocorticoid receptor: into the nucleus and back. Traffic (2011) 1.16
The role of FKBP5 in cancer aetiology and chemoresistance. Br J Cancer (2010) 1.14
CD74 in antigen presentation, inflammation, and cancers of the gastrointestinal tract. World J Gastroenterol (2009) 1.10
Morphologic investigations on the rebound phenomenon after corticosteroid-induced atrophy in human skin. J Invest Dermatol (1984) 1.09
Glucocorticoid elevation of dexamethasone-induced gene 2 (Dig2/RTP801/REDD1) protein mediates autophagy in lymphocytes. J Biol Chem (2011) 1.08
Nuclear reprogramming of luminal-like breast cancer cells generates Sox2-overexpressing cancer stem-like cellular states harboring transcriptional activation of the mTOR pathway. Cell Cycle (2013) 1.08
Role of dual specificity phosphatases in biological responses to glucocorticoids. J Biol Chem (2008) 1.08
Content-based microarray search using differential expression profiles. BMC Bioinformatics (2010) 1.07
Rapamycin is a potent inhibitor of skin tumor promotion by 12-O-tetradecanoylphorbol-13-acetate. Cancer Prev Res (Phila) (2011) 1.07
Targeting inflammation using selective glucocorticoid receptor modulators. Curr Opin Pharmacol (2010) 1.05
Characterization of ZK 245186, a novel, selective glucocorticoid receptor agonist for the topical treatment of inflammatory skin diseases. Br J Pharmacol (2009) 1.05
Chemical inhibition of RNA viruses reveals REDD1 as a host defense factor. Nat Chem Biol (2011) 1.04
Glucocorticoids and bone: local effects and systemic implications. Trends Endocrinol Metab (2014) 1.03
A case of fat injection for treating subcutaneous atrophy caused by local administration of corticosteroid. Tokai J Exp Clin Med (2010) 1.01
Corticosteroid atrophy in human skin. A study by light, scanning, and transmission electron microscopy. J Invest Dermatol (1983) 1.00
A milieu of regulatory elements in the epidermal differentiation complex syntenic block: implications for atopic dermatitis and psoriasis. Hum Mol Genet (2010) 0.99
Novel steroid receptor phyto-modulator compound a inhibits growth and survival of prostate cancer cells. Cancer Res (2008) 0.99
REDD1 protects osteoblast cells from gamma radiation-induced premature senescence. PLoS One (2012) 0.97
Induction of a cell stress response gene RTP801 by DNA damaging agent methyl methanesulfonate through CCAAT/enhancer binding protein. Biochemistry (2005) 0.96
The hairless mouse model for assaying the atrophogenicity of topical corticosteroids. Acta Derm Venereol (1992) 0.93
Insight into the molecular mechanisms of glucocorticoid receptor action promotes identification of novel ligands with an improved therapeutic index. Exp Dermatol (2006) 0.92
The mechanisms of tumor suppressor effect of glucocorticoid receptor in skin. Mol Carcinog (2007) 0.91
It takes two to tango: dimerisation of glucocorticoid receptor and its anti-inflammatory functions. Steroids (2012) 0.90
Identification of novel in vitro test systems for the determination of glucocorticoid receptor ligand-induced skin atrophy. Skin Pharmacol Physiol (2009) 0.90
The tumor suppressor effect of the glucocorticoid receptor in skin is mediated via its effect on follicular epithelial stem cells. Oncogene (2006) 0.88
Comparative evaluation of skin atrophy in man induced by topical corticoids. Br J Dermatol (1979) 0.85
RTP801 is required for ceramide-induced cell-specific death in the murine lung. Am J Respir Cell Mol Biol (2012) 0.85
Regulated in development and DNA damage responses -1 (REDD1) protein contributes to insulin signaling pathway in adipocytes. PLoS One (2012) 0.83
Tachyphylaxis to topical glucocorticoids; what is the evidence? Dermatol Online J (2013) 0.77
Investigation of the skin thinning effect of prednicarbate and other corticoids in mouse skin. Skin Pharmacol (1988) 0.76
Selective Activator of the Glucocorticoid Receptor Compound A Dissociates Therapeutic and Atrophogenic Effects of Glucocorticoid Receptor Signaling in Skin. J Cancer Prev (2015) 0.76
Important role of kallikrein 6 for the development of keratinocyte proliferative resistance to topical glucocorticoids. Oncotarget (2016) 0.75
The long winding road to the safer glucocorticoid receptor (GR) targeting therapies. Oncotarget (2022) 0.75